Literature DB >> 6766905

Resistance to listeriosis in mice that are deficient in the fifth component of complement.

J C Petit.   

Abstract

Infection with Listeria monocytogenes was studied in strains of mice with genetic absence of the fifth component of complement (C5). Mice deficient in C5 consistently showed an increased growth of Listeria in their spleens as compared to normal mice. This increased growth was not corrected by administration of plasma containing C5. Furthermore, depletion of C5 and terminal complement components by administration of cobra venom factor did not impair the resistance to Listeria infection of normal mice. No phagocytic defect could be detected in macrophages from strains lacking C5. Transfer of bone marrow cells from C5+ but not from C5- mice corrected the marked increase of Listeria growth in mice having blockade of the reticuloendothelial system. We hypothesize that the defect of mice lacking C5 lies not in the absence of serum C5 but somewhere at the level of the macrophage.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766905      PMCID: PMC550722          DOI: 10.1128/iai.27.1.61-67.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  A SINGLE GENE CONTROLLING HEMOLYTIC COMPLEMENT AND A SERUM ANTIGEN IN THE MOUSE.

Authors:  R P ERICKSON; D K TACHIBANA; L A HERZENBERG; L T ROSENBERG
Journal:  J Immunol       Date:  1964-04       Impact factor: 5.422

2.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  Susceptibility of C5-deficient mice to listeriosis: modulation by Concanavalin A.

Authors:  D A Lawrence; R F Schell
Journal:  Cell Immunol       Date:  1978-09       Impact factor: 4.868

4.  Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.

Authors:  H J Müller-Eberhard; K E Fjellström
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

5.  Hereditary deficiency of the second component of complement (C2) in man: correlation of C2 haemolytic activity with immunochemical measurements of C2 protein.

Authors:  S Ruddy; M R Klemperer; F S Rosen; K F Austen; J Kumate
Journal:  Immunology       Date:  1970-06       Impact factor: 7.397

6.  Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity.

Authors:  R Snyderman; M C Pike; D McCarley; L Lang
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

7.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

8.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

9.  The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri.

Authors:  L D Caren; L T Rosenberg
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

10.  THE PASSIVE TRANSFER OF ACQUIRED RESISTANCE TO LISTERIA MONOCYTOGENES.

Authors:  K MIKI; G B MACKANESS
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  10 in total

1.  In vitro kinetics of phagocytosis and intracellular killing of gonococci by peritoneal macrophages from mice deficient in complement component 5.

Authors:  M D Cooper; S A Floyd
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

2.  Depression by Pseudomonas aeruginosa of two T-cell-mediated responses, anti-Listeria immunity and delayed-type hypersensitivity to sheep erythrocytes.

Authors:  J C Petit; G Richard; B Albert; G L Daguet
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

3.  Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity.

Authors:  C J Czuprynski; B P Canono; P M Henson; P A Campbell
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

4.  Alteration of cell-mediated immunity to Listeria monocytogenes in protein-malnourished mice treated with thymosin fraction V.

Authors:  T M Petro; G Chien; R R Watson
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

5.  Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

Authors:  M C Cerquetti; D O Sordelli; R A Ortegon; J A Bellanti
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

6.  Suppression of immune response to Listeria monocytogenes: mechanism(s) of immune complex suppression.

Authors:  H W Virgin; G F Wittenberg; G J Bancroft; E R Unanue
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

7.  Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells.

Authors:  R F Tsuji; G P Geba; Y Wang; K Kawamoto; L A Matis; P W Askenase
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

Review 8.  Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment.

Authors:  Jamie C DeWitt; Dori R Germolec; Robert W Luebke; Victor J Johnson
Journal:  Curr Protoc Toxicol       Date:  2016-02-01

9.  Septicaemia models using Streptococcus pneumoniae and Listeria monocytogenes: understanding the role of complement properdin.

Authors:  Aline Dupont; Fatima Mohamed; Nur'Ain Salehen; Sarah Glenn; Lorenza Francescut; Rozita Adib; Simon Byrne; Hannah Brewin; Irina Elliott; Luke Richards; Petya Dimitrova; Wilhelm Schwaeble; Nina Ivanovska; Aras Kadioglu; Lee R Machado; Peter W Andrew; Cordula Stover
Journal:  Med Microbiol Immunol       Date:  2014-04-12       Impact factor: 3.402

10.  Associating changes in the immune system with clinical diseases for interpretation in risk assessment.

Authors:  Michael I Luster; Dori R Germolec; Christine G Parks; Laura Blaciforti; Michael Kashon; Robert Luebke
Journal:  Curr Protoc Toxicol       Date:  2004
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.